Actively Recruiting
PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE
Led by Azienda Ospedaliero-Universitaria Careggi · Updated on 2021-08-26
180
Participants Needed
1
Research Sites
313 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This observational study was designed to evaluate progression free survival after PSMA-PET/CT based salvage approach for patients affected by biochemical relapse after radical prostatectomy.
CONDITIONS
Official Title
PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent
- Age over 18 years
- Suitable for 68Ga-PSMA PET/CT restaging
- Previous radical prostatectomy with histological confirmation of prostate adenocarcinoma
- Biochemical relapse defined as PSA greater than 0.2 and less than 1 ng/ml
You will not qualify if you...
- Androgen deprivation therapy (ADT) within 6 months before enrollment
- Persistent elevated PSA over 0.1 ng/ml measured within 16 weeks after surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
AOU Careggi Radiation Oncology Unit
Florence, Italy, 50134
Actively Recruiting
Research Team
L
Lorenzo Livi, Prof.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here